King Faisal Specialist Hospital and Research Centre (KFSHRC) has reinforced its leading position in Saudi Arabia’s healthcare ...

University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

Study’s Dose Escalation Safety Committee approves initiation of Cohort 2 with fourth patient to receive increase in initial dose pending ...

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

The first week of May, Lindsey Warmouth got news that she was pregnant. In the third week, that her 8-year-old son had cancer ...

In a moment that could only make fans of either team smile, 8-year-old cancer survivor Wesley Hines-Allen accompanied his ...

October 12, 2025 - PORTERVILLE, Calif. — A cutting-edge cancer treatment that reprograms the body’s own immune cells saved a Porterville child’s life — and it’s coming soon to Valley Children’s, ...

NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Eight years after Novartis AG gained U.S. FDA approval of the first CAR T therapy, Kymriah (tisagenlecleucel), for B-cell ...